| scholarly article | Q13442814 |
| P50 | author | Kim Rouven Liedtke | Q61470491 |
| Eun Ha Choi | Q61782557 | ||
| Eric Freund | Q91211731 | ||
| P2093 | author name string | Kristian Wende | |
| Nagendra Kumar Kaushik | |||
| Sander Bekeschus | |||
| Lars-Ivo Partecke | |||
| Amanda Heidecke | |||
| Lea Miebach | |||
| P2860 | cites work | Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. | Q42831305 |
| Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy | Q43179865 | ||
| Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy | Q45255751 | ||
| Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q45343898 | ||
| mTOR signaling pathway is a target for the treatment of colorectal cancer. | Q45973857 | ||
| Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study | Q46465639 | ||
| FPHPB inhibits gastric tumor cell proliferation by inducing G2-M cell cycle arrest | Q47229389 | ||
| Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression | Q47232136 | ||
| Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. | Q47614555 | ||
| Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein. | Q47704520 | ||
| Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines. | Q48158087 | ||
| Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen. | Q48301373 | ||
| Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy | Q48622288 | ||
| Generation of highly differentiated BHY oral squamous cell carcinoma multicellular spheroids. | Q49769585 | ||
| Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma | Q50103945 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS | Q23923062 | ||
| Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways | Q24299771 | ||
| Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways | Q24309037 | ||
| Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. | Q24533236 | ||
| Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease | Q24617270 | ||
| The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website | Q24645514 | ||
| A comprehensive pathway map of epidermal growth factor receptor signaling | Q24672490 | ||
| Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer | Q26795466 | ||
| Ten things you should know about protein kinases: IUPHAR Review 14 | Q26849417 | ||
| Signal transduction by receptors with tyrosine kinase activity | Q27860624 | ||
| Therapeutic options for peritoneal metastasis arising from colorectal cancer | Q28067123 | ||
| High frequency of mutations of the PIK3CA gene in human cancers | Q28131776 | ||
| Calreticulin exposure dictates the immunogenicity of cancer cell death | Q28280438 | ||
| Role of redox signaling regulation in propyl gallate-induced apoptosis of human leukemia cells | Q39626678 | ||
| Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21. | Q39680307 | ||
| Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells | Q40074538 | ||
| Clinical perspective of human colorectal cancer metastasis | Q40198558 | ||
| Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records | Q40205582 | ||
| ROS up-regulation mediates Ras-induced changes of cell morphology and motility | Q40290343 | ||
| ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. | Q40428511 | ||
| Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis | Q40525018 | ||
| Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways | Q40656830 | ||
| Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis | Q40929895 | ||
| Protein kinase C: a novel target for inhibiting gastric cancer cell invasion | Q41085730 | ||
| Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. | Q41579047 | ||
| Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes | Q41607785 | ||
| Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids | Q42278474 | ||
| Sensitivity Profiles of Human Prostate Cancer Cell Lines to an 80 Kinase Inhibitor Panel | Q50882931 | ||
| Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer. | Q51000263 | ||
| Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type | Q51101587 | ||
| Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. | Q52164798 | ||
| Calculated cell-specific intracellular hydrogen peroxide concentration: Relevance in cancer cell susceptibility during ascorbate therapy. | Q52336859 | ||
| The Target of Rapamycin and Mechanisms of Cell Growth. | Q52353013 | ||
| Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species-independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells. | Q52718232 | ||
| ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. | Q52861120 | ||
| Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. | Q52873895 | ||
| Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution. | Q52952846 | ||
| Pancreatic Cancer | Q54135367 | ||
| HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. | Q54170195 | ||
| Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies. | Q55100687 | ||
| Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy. | Q55476449 | ||
| Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells. | Q55646738 | ||
| ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis | Q57267073 | ||
| Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction | Q58708143 | ||
| Oxygen diffusion in ellipsoidal tumour spheroids | Q58776153 | ||
| Assays for the Measurement of Lipid Peroxidation | Q61167512 | ||
| Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells | Q64271992 | ||
| Protein kinase C | Q67823809 | ||
| Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus | Q69429339 | ||
| Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases | Q71143796 | ||
| Internal tandem duplication of the flt3 gene found in acute myeloid leukemia | Q71841108 | ||
| Synergistic Killing of Ehrlich Ascites Carcinoma Cells by Ascorbate and 3-Amino-1,2,4,-triazole | Q72364001 | ||
| Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies | Q74305447 | ||
| Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor | Q77393484 | ||
| Ionizing radiation-induced micronucleus formation is mediated by reactive oxygen species that are produced in a manner dependent on mitochondria, Nox1, and JNK | Q80051517 | ||
| Tyrosine kinases as targets for cancer therapy | Q80367757 | ||
| Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells | Q89040090 | ||
| Elevated H2AX Phosphorylation Observed with kINPen Plasma Treatment Is Not Caused by ROS-Mediated DNA Damage but Is the Consequence of Apoptosis | Q90886686 | ||
| ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy | Q91113042 | ||
| Non-Thermal Plasma-Induced Immunogenic Cell Death in Cancer: A Topical Review | Q93107391 | ||
| ASK1 is essential for JNK/SAPK activation by TRAF2 | Q28285612 | ||
| Epidermal growth factor-related peptides and their receptors in human malignancies | Q28293442 | ||
| Phosphorylation-Dephosphorylation of Enzymes | Q28306047 | ||
| Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling | Q28388989 | ||
| Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling | Q28389739 | ||
| Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin | Q28475626 | ||
| Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase | Q28583309 | ||
| The landscape of somatic copy-number alteration across human cancers | Q29547648 | ||
| mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt | Q29547767 | ||
| Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? | Q29616804 | ||
| Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy | Q29617584 | ||
| Autoinhibition of Bcr-Abl through its SH3 domain | Q30164601 | ||
| Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. | Q30408769 | ||
| A metabolic model describing the H2O2 elimination by mammalian cells including H2O2 permeation through cytoplasmic and peroxisomal membranes: comparison with experimental data | Q30948018 | ||
| Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. | Q32073544 | ||
| Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. | Q33345134 | ||
| Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review | Q33612653 | ||
| Oxidative stress and gene regulation | Q33853144 | ||
| Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. | Q33956668 | ||
| Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer | Q33967933 | ||
| Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. | Q34005286 | ||
| Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha | Q34190131 | ||
| Immunogenic cell death and DAMPs in cancer therapy | Q34311701 | ||
| Age-related changes in protein oxidation and proteolysis in mammalian cells. | Q34420880 | ||
| Role of tyrosine kinase inhibitors in cancer therapy | Q34432091 | ||
| European cancer mortality predictions for the year 2014. | Q34661464 | ||
| Smart drugs: tyrosine kinase inhibitors in cancer therapy | Q34710595 | ||
| Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. | Q34792865 | ||
| Why the epidermal growth factor receptor? The rationale for cancer therapy | Q34803451 | ||
| Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany | Q34874076 | ||
| High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer | Q34979095 | ||
| Proteomic and redox-proteomic study on the role of glutathione reductase in human lung cancer cells | Q35014058 | ||
| Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells | Q35085222 | ||
| Photodynamic therapy of cancer: an update | Q35532394 | ||
| Signaling through the epidermal growth factor receptor during the development of malignancy | Q35729447 | ||
| Cellular responses to EGFR inhibitors and their relevance to cancer therapy | Q36003118 | ||
| Signaling circuitries controlling stem cell fate: to be or not to be. | Q36081663 | ||
| Peroxiporin Expression Is an Important Factor for Cancer Cell Susceptibility to Therapeutic H2O2: Implications for Pharmacological Ascorbate Therapy. | Q36255595 | ||
| Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death | Q36301061 | ||
| Screening of breast cancer stem cell inhibitors using a protein kinase inhibitor library. | Q36306909 | ||
| Chemotherapy and targeted therapy combinations in advanced melanoma | Q36445966 | ||
| The rate of cellular hydrogen peroxide removal shows dependency on GSH: mathematical insight into in vivo H2O2 and GPx concentrations | Q36498664 | ||
| Cellular senescence and cancer treatment. | Q36616891 | ||
| Redox signalling in anchorage-dependent cell growth | Q36699648 | ||
| In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. | Q36757194 | ||
| The immune system evolved to discriminate infectious nonself from noninfectious self | Q36774100 | ||
| Redox regulation of cell survival | Q37181226 | ||
| Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. | Q37252019 | ||
| Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment | Q37283952 | ||
| Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway. | Q37427658 | ||
| Aquaporin-3 mediates hydrogen peroxide-dependent responses to environmental stress in colonic epithelia | Q37598979 | ||
| mTOR pathway in colorectal cancer: an update | Q37649634 | ||
| Triethylenetetramine Synergizes with Pharmacologic Ascorbic Acid in Hydrogen Peroxide Mediated Selective Toxicity to Breast Cancer Cell | Q37657421 | ||
| Rapamycin: one drug, many effects | Q37679469 | ||
| Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance | Q38081267 | ||
| Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways | Q38110922 | ||
| Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments | Q38119845 | ||
| ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. | Q38184935 | ||
| Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches | Q38198444 | ||
| 3D cell culture systems: advantages and applications | Q38218818 | ||
| Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems | Q38495033 | ||
| Synthesis and anticancer activity of lavendustin A derivatives containing arylethenylchromone substituents | Q38509970 | ||
| Drug-induced amino acid deprivation as strategy for cancer therapy | Q38657061 | ||
| Modeling Physiological Events in 2D vs. 3D Cell Culture | Q38671020 | ||
| Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review | Q38729978 | ||
| Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory | Q38827897 | ||
| Immunogenic cell death in cancer and infectious disease | Q38982422 | ||
| ROS-Ca(2+) is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosis | Q39606867 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P577 | publication date | 2020-01-02 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells in vitro | |
| P478 | volume | 12 |
| Q99555687 | Plasma in Cancer Treatment | cites work | P2860 |
Search more.